The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

📢 The Cancer Drug Development Forum (CDDF) is delighted to inform you that its executive summary of the Annual Conference 2023 has been published and is available to all our stakeholders.

The 2023 edition of the multi-stakeholder conference took place on 6-8 February 2023 in Noordwijk aan zee, NL. It brought together the community of cancer research in order to address challenges in clinical trial performance. With our renowned speakers and audience with diverse backgrounds, it generated fruitful discussions and interactive dialogue, placing strong emphasis on collaborative approaches and patient empowerment.

Click here to read the executive summary 📜 to learn more about our discussions and watch the CDDF’s video 📺 to get a glimpse of the Annual Conference.



Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70